Quince Therapeutics (QNCX) Operating Leases (2019 - 2026)
Quince Therapeutics (QNCX) posted quarterly Operating Leases of $293000.0 for Q1 2026, down 23.5% year-over-year from $383000.0 in Q1 2025, and down 11.21% quarter-over-quarter from $330000.0 in Q4 2025.
Quince Therapeutics (QNCX) Operating Leases (2019 - 2026) Analysis & Trends
Quince Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $293000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 23.5% year-over-year to $293000.0; the TTM figure through Mar 2026 stood at $293000.0 (down 23.5% YoY), while the FY2025 annual figure was $330000.0, down 16.24% from the prior year.
- Operating Leases for Q1 2026 stood at $293000.0, down from $330000.0 in the prior quarter.
- The five-year high for Operating Leases was $547000.0 in Q2 2024, with the low at $34000.0 in Q3 2022.
- The 5-year median for Operating Leases is $383000.0 (2025), against an average of $327076.9.
- The sharpest annual moves came in 2022 and 2024: Operating Leases sank 94.43% in 2022, then gained 2.34% in 2024.
- Quince Therapeutics' Operating Leases stood at $34000.0 in 2022, then soared by 1032.35% to $385000.0 in 2023, then rose by 2.34% to $394000.0 in 2024, then fell by 16.24% to $330000.0 in 2025, then slipped by 11.21% to $293000.0 in 2026.
- Business Quant data shows QNCX's Operating Leases at $293000.0 in Q1 2026, $330000.0 in Q4 2025, and $359000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293,000.00 |
| Dec 31, 2025 | 330,000.00 |
| Sep 30, 2025 | 359,000.00 |
| Jun 30, 2025 | 387,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 394,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 547,000.00 |
| Mar 31, 2024 | 394,000.00 |
| Dec 31, 2023 | 385,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 420,000.00 |
| Sep 30, 2021 | 610,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 171,000.00 |
| Dec 31, 2020 | 208,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Jun 30, 2020 | 50,000.00 |